Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
60 / 100
AltIndex AI Score
Hold
AI Score · 12-mo trend
−8 pts over 3 months50% of ATRC’s tracked signals bullish
FundamentalsNeutral
TechnicalsBullish
Alternative dataBullish
SentimentNeutral
Price$57.78
Year Range$25.86 – $60.77
Market Cap$2.91B
PE Ratio272.86
IndustryMedical & Dental Instruments

What Is Atricure’s AI Stock Analysis?

Atricure’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Atricure’s momentum in near-real time.

Atricure (ATRC) has an AltIndex AI Score of 60/100, currently a Hold signal. The AI Score distills Atricure's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.

Atricure’s Full AI Analysis

AtriCure, Inc. (Nasdaq: ATRC) is a medical device company that provides innovative solutions for the treatment of atrial fibrillation (AF) and related conditions. The company is a leader in the development and commercialization of advanced surgical treatments including minimally invasive procedures. Its product portfolio is comprised of cutting-edge technologies that cater to hospitals, surgical centers, and cardiac centers globally.

Fundamental Analysis

Revenue for the last quarter was $154 million. This is an increase of 8.75% compared to the previous quarter, highlighting a positive growth trajectory. When compared to the same quarter last year, the revenue represents a growth of 12.83%. These increases signal a healthy year-over-year growth, suggesting a consistently increasing demand for AtriCure’s products.

Premium

Keep reading AltIndex’s full AI analysis of Atricure — the fundamental, technical and alternative-data breakdown and the recommendation.

Sign up to read the full analysis

What’s Driving ATRC’s AI Score?

Fundamentals

Revenue for the last quarter was $154M. This is an increase of 8.75% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of 12.83%, suggesting positive year-over-year growth. Net income for the last quarter was $9M. This is an increase of 8,191.67% compared to the quarter before it, which is a positive sign of growth. Compared to the same quarter last year, there is an increase of -244.67%, suggesting positive year-over-year growth. Ebitda for the last quarter was $3.2M. This represents a decrease of 54.56% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 334.97%, suggesting positive year-over-year growth. The current P/E ratio is 272.86. This may be considered high, potentially indicating overvaluation and a bearish outlook. In the last couple of months, there's been a couple of company insiders selling their stock, a potentially bearish signal.

See Atricure’s earnings and insider transactions.

Technicals

Today's stock price is $57.78. This is an increase of 1.12% compared to a month ago, indicating a positive short-term trend. Compared to a year ago, there is an increase of 55.49%, suggesting a positive long-term trend. The trend is bullish. The current SMA10 is $55.65, which is higher than the previous SMA10 of $55.51. This indicates a potential upward trend in price movement. The RSI is 25, indicating a potentially oversold (bullish) condition.

See the full technical analysis and price prediction.

Alternative data

Atricure has an estimated 56 open positions. This number is up by 6% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Atricure is neutral. Atricure has an estimate of 24,000 visitors to their webpage. The number of visitors is up by 85% in the last couple of months, a bullish trend as this can indicate can increase in customers.

Explore Atricure’s job postings, web traffic and app downloads.

Sentiment & social

Atricure has 1,300 followers on their Instagram page. The number of followers is up by 6% in the last couple of months, indicating an increased interest in the company. Atricure has 2,700 followers on their Twitter page. The number of followers is down by -0% in the last couple of months, indicating a loss in interest in the company.

Track Atricure’s market sentiment.

Frequently Asked Questions: Atricure AI Stock Analysis

Atricure's AltIndex AI Score is 60/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.

AltIndex's AI Score model rates Atricure a Hold (60/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.

The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.

AltIndex generates a complete written AI analysis of Atricure — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ATRC AI Score or sign up to read the full thesis.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.